Carolina Garcia Olmos Calil , MD

Jair C. Soares, MD, PhD, is a board-certified specialist and a renowned educator in the field of psychiatry. He received his medical degree from the in Brazil. He then went on to complete his general psychiatry residency at the University of Pittsburgh, and his brain imaging fellowship at Yale University.Before his time at UTHealth Houston, Soares served as a professor at the University of North Carolina at Chapel Hill. He was a deputy chair and division chief for the Department of Psychiatry at UT Health San Antonio. Throughout his academic career, Soares has published over 350 peer-reviewed articles, held several editorial positions at national and international medical journals, and received research funding from several federal and private institutions. Soares currently serves as the vice president for the National Network of Depression Centers, and is on the executive council, finance committee, and travel award committee for the International Society for Clinical Trials Methodology.Soares began his career at UTHealth Houston in 2009 when he became the professor and chair of the Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston. Now, he serves as the vice president of Behavioral Sciences at UTHealth Houston, and the director of the UTHealth Houston Center of Excellence on Mood Disorders. Soares also serves as the executive director of the John S. Dunn Behavioral Sciences Center and the UTHealth Houston Harris County Psychiatric Center. There, he leads the largest academic behavioral health complex in the nation. Soares also oversees the psychiatry services at two local Houston hospitals; Memorial Hermann-Texas Medical Center and Harris Health Lyndon B. Johnson Hospital.In February 2024, Soares was named as the founding dean of UTHealth Houston School of Behavioral Health Sciences. He will begin work to not only build the school's funding and reputation, but to build the school's curriculum and course foundation. Soares wants to focus on training, the understanding of underlying mechanisms, and a commitment to providing care for patients. He strives to educate and create the next generation of experienced health care workers in mental health specialties so they can provide quality care to patients across Texas.

Meet Dr. Mira Milad an accomplished M.D. based in Houston TX. With a specialization in General Allopathic Medicine Dr. Milad is dedicated to providing top-notch medical care to her patients. As a Doctor of Medicine Dr. Milad holds expertise in a wide range of medical areas ensuring comprehensive healthcare solutions for those under her care. Her practice in Houston serves as a beacon of quality medical services in the community. Generated from this place's public information

Paul Schulz, M.D., is a professor of neurology at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). He received his combined BA-MD degrees from Boston University in 1984. He did a medical internship there, and moved to Baylor College of Medicine for his residency in Neurology. He stayed for a laboratory fellowship in cellular neurophysiology after which he became an assistant professor. Later, he was an associate professor of neurology, neuroscience, and translational biology and molecular medicine. Dr. Schulz was also the vice chair of education for neurology, the deputy chair of the Methodist neurology service, and directed the Cognitive Disorders Clinics at Baylor and the Houston Veterans Administration Hospital. Dementia Program In 2010, Dr. Schulz moved to Mischer Neuroscience Institute, where he sees patients who have cognitive, behavioral, or mood disorders. His group is investigating risk factors for dementia in order to understand why it develops, including both environmental and genetic factors. They use imaging, epidemiologic, and genetic approaches and have identified several risk factors. They are also investigating ways to diagnose dementia earlier, perhaps before symptoms develop, in order to determine whether interventions in the presymptomatic stage might delay or prevent the development of dementia. His group has early data suggesting that the treatment of some risk factors may reduce the probability of developing dementia. Dr. Schulz has received numerous awards and has been an invited speaker at major scientific meetings worldwide. He has been extensively published in the scientific literature and has been featured on television and radio shows.